Pharmaceutical Business Review
Anonymous User | Login

Simcere Signs Strategic Partnership With Sun Yat-Sen University Cancer Center

Published: 24-Aug-2009

To research and develop anti-cancer drugs

Simcere has signed a strategic partnership with Sun Yat-Sen University Cancer Center in China. Under the agreement, Simcere and Sun Yat-Sen University Cancer Center will cooperate on researching and developing anti-cancer drugs, as well as conducting a joint training program to develop personnel in advanced R&D.

Jinsheng Ren, chairman and CEO of Simcere, said: We are delighted to enter into a strategic partnership with Sun Yat-Sen University Cancer Center. I am confident that this cooperation will enhance Simcere's R&D capabilities and contribute to the future development of innovative cancer drugs in China.

Simcere is a manufacturer and supplier of branded generic pharmaceuticals, and producer of the patented anti-cancer drug - Endu, in the Chinese market.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

ADAPT Localization

The Translation and Localization Specialists ...

Altiora

To Strive for the Highest ...

Aptuit

Drug Discovery and Development ...

Axiom Real Time Metrics

EDC Solutions ...

BioKinetic Europe

Phase I/II Contract Research Organisation ...

Business Region Göteborg

Cultivating Academic Research and Commercial Innovations and Adaptations Within the Health Care Syst...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Your IP at Risk in Collaborations!

Free white paper: Ten steps to protect your R&D investment within partnerships. ...

Why, When and How to Conduct 14C Human Studies

Several risk-based strategies to assess metabolites exist. Whatever the strategy chosen, t ...

Why CAPA Still Matters

This free white paper explores the needs and effectiveness of correct CAPA control, how to ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Using the Mean Kinetic Temperature (MKT) As a Parameter to Determine Whether Perishable Goods Have Been Transported and Stored Correctly

Tecnosoft systems use MKT calculation to control the acquired values and report the user w ...

USB HotStart-IT for Real Time PCR

USB® Products from Affymetrix have a long-standing reputation in the life science marketpl ...

Related Companies

No items to display

Suppliers Product News

Aptuit Outlines 2010 Business Priorities at 28th Annual J.P. Morgan Healthcare Conference

Aptuit, Inc., a contract development and manufacturing company, today will provide an update on 2010 business priorities and discuss its integrated service offerings at the 28th Annual J.P. Morgan Healthcare Conference in San Francisco.

Aptuit Publishes Study which Demonstrates the Value of Early Insights into the Characterisation of Drug Compounds

New research on the solid-state characterisation of finasteride clearly outlines a systematic approach to characterising and monitoring active pharmaceutical ingredients

Aptuit Launches Program to Accelerate Early Stage Drug Development

Aptuit INDiGO™ accelerates drug development from pre-clinical candidate selection to regulatory filing on a fixed timeline and price

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address